Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.

Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KV.

Rheumatology (Oxford). 2012 Nov;51(11):2004-12. doi: 10.1093/rheumatology/kes183. Epub 2012 Jul 23.

PMID:
22829689
[PubMed - indexed for MEDLINE]
2.

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.

PMID:
18331118
[PubMed - indexed for MEDLINE]
Free Article
3.

Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks.

Lynch W, Chan W, Kleinman N, Andrews LM, Yadao AM.

Popul Health Manag. 2013 Apr;16(2):138-45. doi: 10.1089/pop.2012.0057. Epub 2012 Oct 31.

PMID:
23113634
[PubMed - indexed for MEDLINE]
4.

Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.

Friedman HS, Yawn BP.

Curr Med Res Opin. 2007 Feb;23(2):427-34.

PMID:
17288696
[PubMed - indexed for MEDLINE]
5.

Managing problem gout.

Fam AG.

Ann Acad Med Singapore. 1998 Jan;27(1):93-9. Review.

PMID:
9588282
[PubMed - indexed for MEDLINE]
6.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
[PubMed - indexed for MEDLINE]
7.

Evaluation of health care costs and utilization patterns for patients with gout.

Park H, Rascati KL, Prasla K, McBayne T.

Clin Ther. 2012 Mar;34(3):640-52. doi: 10.1016/j.clinthera.2012.01.020. Epub 2012 Mar 3.

PMID:
22381710
[PubMed - indexed for MEDLINE]
8.

Updates in the management of gout.

Keith MP, Gilliland WR.

Am J Med. 2007 Mar;120(3):221-4. Review.

PMID:
17349440
[PubMed - indexed for MEDLINE]
9.

Gout in ambulatory care settings in the United States.

Krishnan E, Lienesch D, Kwoh CK.

J Rheumatol. 2008 Mar;35(3):498-501. Epub 2008 Feb 1.

PMID:
18260174
[PubMed - indexed for MEDLINE]
10.

A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis.

Ferraz MB, O'Brien B.

J Rheumatol. 1995 May;22(5):908-14.

PMID:
8587081
[PubMed - indexed for MEDLINE]
11.

Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.

Bickston SJ, Waters HC, Dabbous O, Tang BI, Rahman M.

J Manag Care Pharm. 2008 May;14(4):352-62.

PMID:
18500913
[PubMed - indexed for MEDLINE]
Free Article
12.

Management of acute and chronic gouty arthritis: present state-of-the-art.

Schlesinger N.

Drugs. 2004;64(21):2399-416. Review.

PMID:
15481999
[PubMed - indexed for MEDLINE]
13.
14.

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.

Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.

Clin Ther. 2009 Nov;31(11):2653-64. doi: 10.1016/j.clinthera.2009.11.032.

PMID:
20110008
[PubMed - indexed for MEDLINE]
15.

Gouty arthritis: understanding the disease state and management options in primary care.

Sunkureddi P.

Adv Ther. 2011 Sep;28(9):748-60. doi: 10.1007/s12325-011-0058-5. Epub 2011 Aug 31. Review.

PMID:
21894471
[PubMed - indexed for MEDLINE]
16.

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.

Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK.

Ann Rheum Dis. 2012 Nov;71(11):1839-48. doi: 10.1136/annrheumdis-2011-200908. Epub 2012 May 14.

PMID:
22586173
[PubMed - indexed for MEDLINE]
17.

[Clinical features of gout in a cohort of Italian patients].

Zampogna G, Andracco R, Parodi M, Cimmino MA.

Reumatismo. 2009 Jan-Mar;61(1):41-7. Italian.

PMID:
19370187
[PubMed - indexed for MEDLINE]
18.

Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.

Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR.

Curr Med Res Opin. 2009 Jul;25(7):1711-9. doi: 10.1185/03007990903017966.

PMID:
19485724
[PubMed - indexed for MEDLINE]
19.

Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.

Delea TE, Gokhale M, Makin C, Hussein MA, Vanderpoel J, Sandman T, Chang J, Sung J, Pinkston P, Gause D, Jackson M.

J Manag Care Pharm. 2007 May;13(4):349-59.

PMID:
17506601
[PubMed - indexed for MEDLINE]
Free Article
20.

The effect of serum urate on gout flares and their associated costs: an administrative claims analysis.

Halpern R, Fuldeore MJ, Mody RR, Patel PA, Mikuls TR.

J Clin Rheumatol. 2009 Feb;15(1):3-7. doi: 10.1097/RHU.0b013e3181945d2c.

PMID:
19125135
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk